195 related articles for article (PubMed ID: 23017732)
1. Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
Kuroda H; Fujihara K; Takano R; Takai Y; Takahashi T; Misu T; Nakashima I; Sato S; Itoyama Y; Aoki M
J Neuroimmunol; 2013 Jan; 254(1-2):178-82. PubMed ID: 23017732
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble C5b-9 in CSF of neuromyelitis optica.
Wang H; Wang K; Wang C; Qiu W; Lu Z; Hu X
Scand J Immunol; 2014 Feb; 79(2):127-30. PubMed ID: 24313854
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
[TBL] [Abstract][Full Text] [Related]
4. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
Wang H; Wang K; Xu W; Wang C; Qiu W; Zhong X; Dai Y; Wu A; Hu X
J Neurochem; 2012 Jul; 122(1):19-23. PubMed ID: 22469018
[TBL] [Abstract][Full Text] [Related]
7. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
Quan C; Yu H; Qiao J; Xiao B; Zhao G; Wu Z; Li Z; Lu C
Mult Scler; 2013 Mar; 19(3):289-98. PubMed ID: 22864301
[TBL] [Abstract][Full Text] [Related]
8. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
Uzawa A; Mori M; Masuda S; Muto M; Kuwabara S
J Neurol Neurosurg Psychiatry; 2013 May; 84(5):517-22. PubMed ID: 23255728
[TBL] [Abstract][Full Text] [Related]
9. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X
J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953
[TBL] [Abstract][Full Text] [Related]
12. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
[TBL] [Abstract][Full Text] [Related]
13. Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.
Zhang L; Wu A; Zhang B; Chen S; Men X; Lin Y; Lu Z
Mult Scler; 2014 Apr; 20(4):418-23. PubMed ID: 23886831
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
[TBL] [Abstract][Full Text] [Related]
15. Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica.
Zhong XN; Wang HH; Bao J; Li R; Long YM; Lu ZQ; Dai YQ; Qiu W; Hu XQ
Chin Med J (Engl); 2012 Jan; 125(2):270-4. PubMed ID: 22340558
[TBL] [Abstract][Full Text] [Related]
16. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
[TBL] [Abstract][Full Text] [Related]
17. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
18. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K
Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620
[TBL] [Abstract][Full Text] [Related]
20. Enhanced complement consumption in neuromyelitis optica and Behçet's disease patients.
Tüzün E; Kürtüncü M; Türkoğlu R; Içöz S; Pehlivan M; Birişik O; Eraksoy M; Akman-Demir G
J Neuroimmunol; 2011 Apr; 233(1-2):211-5. PubMed ID: 21215465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]